Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-CarboxamidesPer Björk, Tomas Leanderson, David Liberg et al.|PLoS Biology|2009Cited by 358
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumorsAnders Olsson, Tomas Leanderson, Johan Vallon‐Christersson et al.|Molecular Cancer|2010Cited by 90
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancerJohn T. Isaacs, Tomas Leanderson, Роберто Пили et al.|The Prostate|2006Cited by 87